CREATININE, URINE Biomarker

Overview

Urine creatinine measures the amount of creatinine, a waste product of muscle metabolism, excreted by the kidneys into urine. Creatinine is filtered by the glomeruli and almost entirely eliminated in urine, so its excretion reflects kidney filtration and overall urine concentration. Low urine creatinine can indicate impaired kidney function or reduced filtration, while altered values may also be influenced by muscle mass, diet, and certain kidney or muscle disorders. Clinically, urine creatinine is used to assess kidney function directly and to normalize other urinary analytes (such as protein or albumin) using ratios like the urine protein‑creatinine ratio or albumin‑creatinine ratio. This makes urine creatinine a useful biomarker in nephrology, biomonitoring, and epidemiologic studies.

Clinical Use Cases

Evaluation of kidney function as part of creatinine clearance testing, alongside serum creatinine, to estimate glomerular filtration rate.
Screening and monitoring for kidney disease or kidney damage in at‑risk populations.
Normalization of other urinary biomarkers (for example, total protein, microalbumin, environmental chemicals) by expressing their concentration per gram of creatinine to account for urine dilution.
Calculation and interpretation of urine albumin‑creatinine ratio (UACR) and urine protein‑creatinine ratio (UPCR) in diagnosing and monitoring chronic kidney disease and related conditions such as diabetes and hypertension.
Use in large population studies (such as NHANES) for exposure assessment and kidney function evaluation, where urinary analytes are often creatinine‑corrected.
Supporting diagnosis of conditions that affect muscle breakdown or kidney tubular function when urine creatinine is interpreted with clinical context and other tests.

Specimen Types

Random (spot) urine sample.
24‑hour urine collection.
First‑morning void urine (commonly used in reference interval definitions and some protocols).

Measurement Methods

Automated enzymatic creatinine assays on clinical chemistry analyzers (for example, Roche Cobas platforms) for urine specimens.
Modified Jaffe reaction (alkaline picrate method) used in many clinical laboratories to quantify creatinine in urine.
Standard clinical laboratory spectrophotometric methods integrated into routine chemistry panels.

Test Preparation and Influencing Factors

Collection type and timing: Results vary over the day, so 24‑hour collections are often used to obtain total daily excretion; random samples are acceptable when results are expressed as ratios (for example, UACR, UPCR).
Diet: High meat intake prior to testing can increase creatinine production and affect urine and serum creatinine levels; patients may be asked to avoid meat for a period before some creatinine tests.
Muscle mass and body size: Normal urine creatinine excretion depends on lean body mass and is often expressed per kilogram of body weight per day.
Hydration status and urine concentration: Dilute or concentrated urine affects raw creatinine concentrations, which is why creatinine‑corrected values or ratios are commonly used.
Kidney function: Reduced glomerular filtration or tubular injury can lower urine creatinine excretion and alter interpretation of ratios with other analytes.
Medications or conditions that affect renal blood flow or muscle metabolism (such as rhabdomyolysis, severe infection, heart failure) may change creatinine generation or excretion and thus urine creatinine levels.
Collection quality: Incomplete 24‑hour urine collection, timing errors, or contamination can significantly distort measured daily urine creatinine.